Bill Rastetter, chairman of cancer diagnostics developer Grail, has added the role of chief executive to his responsibilities at the Menlo Park, CA, company. With Rastetter’s appointment, Grail founding CEO Jeff Huber will become vice chairman of the board of directors. Grail also promoted chief business officer Ken Drazan to president. Grail spun out from gene sequencing firm Illumina (NASDAQ: [[ticker: ILMN]]) last year, backed by a $100 million Series A round of financing.
Author: Frank Vinluan
Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.
View all posts by Frank Vinluan
